Bretagne S, Vidaud M, Kuentz M, Cordonnier C, Henni T, Vinci G, Goossens M, Vernant J P
INSERM U.91, Department of Genetics, Creteil, France.
Blood. 1987 Nov;70(5):1692-5.
We have used DNA sequence polymorphism analysis to document engraftment after T cell-depleted bone marrow transplantation (BMT), with a selected panel of four DNA probes. In contrast to nondepleted BMT recipients, the patients who received T cell-depleted marrow exhibited a mixed blood chimerism. This mosaicism was observed before graft failure or relapse in six patients. However, in five other patients, this mixed chimerism was not followed by these complications with a follow-up of 9 to 31 months after transplantation. Our results support the hypothesis that transplanted bone marrow T cells may help to maintain engraftment by eliminating host cells that can cause graft failure.